Jason Shields

Jason Shields is a seasoned medicinal chemist with extensive experience in the synthesis and design of biologically active molecules, particularly in the fields of immuno-oncology and DNA damage response. Jason's career includes roles as Senior Scientist and Associate Principal Scientist at AstraZeneca from October 2016 to December 2021, where responsibilities encompassed project progression through interdisciplinary collaboration and ownership of the AI/ML retrosynthesis tool, AiZynth. Prior experience includes a postdoctoral research position at Boston College, graduate studies at Princeton University, and undergraduate research roles at Washington University in St. Louis. Jason's academic credentials were earned at Princeton University from 2010 to 2015.